🇺🇸 FDA
Patent

US 10087240

DNA antibody constructs and method of using same

granted A61KA61K2039/505A61K2039/53

Quick answer

US patent 10087240 (DNA antibody constructs and method of using same) held by Inovio Pharmaceuticals, Inc. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K2039/505, A61K2039/53, A61K2039/54, A61K48/005